Category: Analysis - Page 11 - Psychedelic Alpha

Read more about the article MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics

MAPS PBC Closes $100m Series A, Rebrands to Lykos Therapeutics

Post published:January 5, 2024
Post category:Analysis News

Read more about the article atai Life Sciences Makes $50m Investment in Beckley Psytech

atai Life Sciences Makes $50m Investment in Beckley Psytech

Post published:January 4, 2024
Post category:Analysis News

Read more about the article Kentucky’s $42m Ibogaine Funding Appears Dead in the Water

Kentucky’s $42m Ibogaine Funding Appears Dead in the Water

Post published:December 29, 2023
Post category:Analysis News

Read more about the article BREAKING: MAPS PBC Files New Drug Application for MDMA-Assisted Therapy for PTSD

BREAKING: MAPS PBC Files New Drug Application for MDMA-Assisted Therapy for PTSD

Post published:December 12, 2023
Post category:Analysis News

Read more about the article Pα+: A Nue Lease of Life? Beckley Waves Acquires Struggling At-Home Ketamine Provider Nue Life Health

Pα+: A Nue Lease of Life? Beckley Waves Acquires Struggling At-Home Ketamine Provider Nue Life Health

Post published:November 10, 2023
Post category:Analysis News Pα+

Read more about the article Pα+: MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

Pα+: MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

Post published:November 8, 2023
Post category:Analysis News Pα+

Read more about the article MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics

Post published:November 8, 2023
Post category:Analysis News

Read more about the article Cybin Shares Positive Interim Topline Data for Deuterated Psilocybin Analog Candidate

Cybin Shares Positive Interim Topline Data for Deuterated Psilocybin Analog Candidate

Post published:October 31, 2023
Post category:Analysis News

Read more about the article Analysis: Patent Applications Provide Hints at Terran Biosciences’ Strategy

Analysis: Patent Applications Provide Hints at Terran Biosciences’ Strategy

Post published:July 28, 2023
Post category:Analysis

Read more about the article Non-Hallucinogenic Trip Reports: Searching for the Tabernanthalog Tasters

Non-Hallucinogenic Trip Reports: Searching for the Tabernanthalog Tasters

Post published:July 19, 2023
Post category:Analysis

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.